A reproducible structural brain axis of alcohol use severity.
Authors
Affiliations (35)
Affiliations (35)
- Hector Institute for Artificial Intelligence in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. [email protected].
- Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. [email protected].
- Hector Institute for Artificial Intelligence in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- German Center for Mental Health (DZPG), Partner Site Mannheim - Heidelberg, Ulm, Germany.
- Institute for Translational Psychiatry, University of Münster, Münster, Germany.
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
- Department of Psychiatry, Medical School and University Medical Center OWL, Protestant Hospital of the Bethel Foundation, Bielefeld University, Bielefeld, Germany.
- German Center for Mental Health (DZPG), Site Jena Magdeburg Halle, Halle, Germany.
- Center for Intervention and Research on Adaptive and Maladaptive Brain Circuits Underlying Mental Health (C-I-R-C), Site Jena Magdeburg Halle, Halle, Germany.
- Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine - University of Freiburg, Freiburg, Germany.
- Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
- Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
- Biobank Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
- State Institute of Health I, Bavarian Health and Food Safety Authority, Erlangen, Germany.
- Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
- Institute of Social Medicine, Occupational Medicine and Public Health, Medical Faculty, University of Leipzig, Leipzig, Germany.
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Ultrahigh Field Facility (B.U.F.F.), Berlin, Germany.
- Institute of Medical Psychology, Ludwig-Maximilians-Universität München (LMU), Munich, Germany.
- Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
- Chair of Epidemiology, Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.
- German Center for Mental Health (DZPG), Partner Site Munich, Munich, Germany.
- Department of Psychiatry, University of Münster, Münster, Germany.
- Hertie Institute for AI in Brain Health, University of Tübingen, Tübingen, Germany.
- Tübingen AI Center, University of Tübingen, Tübingen, Germany.
- German Center for Mental Health (DZPG), Partner Site Tübingen, Tübingen, Germany.
- Department of Psychiatry and Psychotherapy, University of Marburg, University Hospital UKGM, Marburg, Germany.
- Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
- Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
Abstract
Alcohol use is linked to distributed structural brain alterations, but population-level alcohol-related neurobiology remains difficult to quantify. We tested whether deep learning-derived MRI representations capture reproducible variation in alcohol consumption severity and converge with clinical and biological markers. Representations were extracted from gray-matter volume maps in the German National Cohort (NAKO; N ≈ 28,000). Ridge-regression scores were derived from structural MRI to estimate alcohol consumption severity, measured with the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C). Models were trained in NAKO, externally validated in UK Biobank (N ≈ 25,000), evaluated in FOR2107 (N ≈ 1900), and tested against ICD-10 alcohol use disorder (AUD), alcohol-related biomarkers, and cognition. In NAKO, the structural MRI-derived ridge-regression score correlated with measured AUDIT-C severity (r = 0.11; 95% CI, 0.09-0.12; q<sub>FDR</sub> = 1.2 × 10<sup>-70</sup>; MAE = 1.64). This association replicated in UK Biobank (r = 0.09; 95% CI, 0.07-0.10; q<sub>FDR</sub> = 4.9 × 10<sup>-41</sup>; MAE = 1.96) and generalized to AUD, with higher odds in the highest versus lowest brain-score quintile (OR = 2.28; 95% CI, 1.49-3.48; q<sub>FDR</sub> = 3.9 × 10<sup>-4</sup>). The score was associated with gamma-glutamyl transferase (β = 1.17 U/L; q<sub>FDR</sub> = 0.007), mean corpuscular volume (β = 14.26 fL; q<sub>FDR</sub> = 4.4 × 10<sup>-4</sup>), and slower reaction time (β = 163.40 ms; q<sub>FDR</sub> = 3.0 × 10<sup>-5</sup>). Deep learning-derived structural MRI representations capture weak but reproducible alcohol-related brain variation that converges with AUD diagnosis, peripheral biomarkers, and cognition, supporting their use in population-level addiction neuroscience while underscoring limits for individual-level prediction.